ASH: Complications Common With Controlled Ovarian Hyperstimulation in Sickle Cell Anemia
Many individuals with sickle cell anemia undergoing controlled ovarian hyperstimulation (COH) with oocyte cryopreservation (OC) have complications, according to a study scheduled for presentation at the annual meeting of the American Society of Hematology, to be held from Dec. 9 to 12 in San Diego.
Marti Goldenberg, D.O., from Johns Hopkins Hospital in Baltimore, and colleagues described clinical factors associated with oocyte recovery and COH complications in sickle cell anemia in a five-center retrospective study. Participants had sickle cell disease and an attempt at OC; all 46 participants had sickle cell anemia.
Source: Advances and More licensed by HealthDay
